✦ LIBER ✦

Insulin Degludec has Similar Pharmacokinetic Properties in Subjects with Renal Impairment and Subjects with Normal Renal Function

✍ Scribed by Kiss, István; Arold, Gerhard; Bøttcher, Susanne G.; Roepstorff, Carsten; Kapor, Jovana; Haahr, Hanne L.

Book ID: 122700603
Publisher: Canadian Diabetes Association
Year: 2012
Tongue: English
Weight: 51 KB
Volume: 36
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2012.07.327

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin Degludec has Similar Pharmacokin

Insulin Degludec has Similar Pharmacokinetic Properties in Subjects with Hepatic Impairment when Compared to Subjects with Normal Hepatic Function

✍ Arold, Gerhard; Kupčová, Viera; Roepstorff, Carsten; Højbjerre, Malene; Nikolov, 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 51 KB

Insulin Degludec: Pharmacokinetic Proper

Insulin Degludec: Pharmacokinetic Properties in Subjects with Hepatic Impairment

✍ Kupčová, Viera; Arold, Gerhard; Roepstorff, Carsten; Højbjerre, Malene; Klim, Sø 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 300 KB

Pharmacokinetics of naproxen in subjects

Pharmacokinetics of naproxen in subjects with normal and impaired renal function

✍ M. Anttila; M. Haataja; A. Kasanen 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 473 KB

Pharmacokinetic and pharmacodynamic prop

Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function

✍ Daniel D. Gretler; Roberto Guerciolini; Paul J. Williams 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Steady-state pharmacokinetics of nefazod

Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function

✍ R. H. Barbhaiya; M. E. Brady; U. A. Shukla; D. S. Greene 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 604 KB

The steady-state pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were compared in subjects with normal and impaired renal function. Patients: The Study was of parallel group design which included 7 subjects with normal (NOR) ren

Pharmacokinetics of enalapril in normal

Pharmacokinetics of enalapril in normal subjects and patients with renal impairment.

✍ JG Kelly; G Doyle; J Donohue; M Laher; MJ Vandenburg; WJ Currie; WD Cooper 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB